{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:07:41Z","timestamp":1792840061204,"version":"4.5.0"},"reference-count":325,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:00:00Z","timestamp":1540252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"British Medical Association Foundation for Medical Research"},{"name":"National Institute of Health Research"},{"name":"University College London Hospitals National Institute of Health Research Biomedical Research Centre"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K501268\/1"],"award-info":[{"award-number":["MR\/K501268\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Society for the Study of Addiction"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.pharmthera.2018.10.006","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T06:43:06Z","timestamp":1540017786000},"page":"132-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":211,"special_numbering":"C","title":["The neuropsychopharmacology of cannabis: A review of human imaging studies"],"prefix":"10.1016","volume":"195","author":[{"given":"Michael A.P.","family":"Bloomfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandni","family":"Hindocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian F.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Petrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Olabisi","family":"Ogunbiyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs G.","family":"Bossong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom P.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2018.10.006_bb0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbr.2010.06.023","article-title":"Functional MRI evidence for inefficient attentional control in adolescent chronic cannabis abuse","volume":"215","author":"Abdullaev","year":"2010","journal-title":"Behavioural Brain Resarch"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1212\/01.wnl.0000253187.66183.9c","article-title":"Cannabis in painful HIV-associated sensory neuropathy - A randomized placebo-controlled trial","volume":"68","author":"Abrams","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0015","series-title":"Cannabis: Report by the Advisory Committee on Drug Dependence (Wootton Report)","author":"Advisory Committee on Drug Dependence","year":"1969"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0020","first-page":"21","article-title":"Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man","volume":"38","author":"Agurell","year":"1986","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugalcdep.2012.07.016","article-title":"Striatal D(2)\/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users","volume":"128","author":"Albrecht","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0030","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","article-title":"Cannabis and schizophrenia - a longitudinal-study of Swedish conscripts","volume":"2","author":"Andreasson","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0035","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1192\/bjp.187.6.510","article-title":"Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases","volume":"187","author":"Arendt","year":"2005","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0040","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuroimage.2008.02.064","article-title":"Corpus callosum damage in heavy marijuana use: preliminary evidence from diffusion tensor tractography and tract-based spatial statistics","volume":"41","author":"Arnone","year":"2008","journal-title":"NeuroImage"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0045","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jpsychires.2011.01.004","article-title":"Medial temporal structures and memory functions in adolescents with heavy cannabis use","volume":"45","author":"Ashtari","year":"2011","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jpsychires.2008.12.002","article-title":"Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use","volume":"43","author":"Ashtari","year":"2009","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0055","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.addbeh.2013.09.012","article-title":"Electrophysiological evidence of early attentional bias to drug-related pictures in chronic cannabis users","volume":"39","author":"Asmaro","year":"2014","journal-title":"Addictive Behaviours"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0060","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1017\/S0033291712001924","article-title":"Cannabis affects people differently: inter-subject variation in the psychotogenic effects of \u0394 9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers","volume":"43","author":"Atakan","year":"2013","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0065","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuropharm.2018.03.032","article-title":"Periaqueductal gray glutamatergic, cannabinoid and vanilloid receptor interplay in defensive behavior and aversive memory formation","volume":"135","author":"Back","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0070","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1177\/0269881110382465","article-title":"Does intravenous \u03949-tetrahydrocannabinol increase dopamine release? A SPET study","volume":"25","author":"Barkus","year":"2011","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0010-0277(94)90018-3","article-title":"Insensitivity to future consequences following damage to human prefrontal cortex","volume":"50","author":"Bechara","year":"1994","journal-title":"Cognition"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0080","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.pnpbp.2010.03.032","article-title":"The impact of early-onset cannabis use on functional brain correlates of working memory","volume":"34","author":"Becker","year":"2010","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0085","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-010-1805-z","article-title":"Altered parahippocampal functioning in cannabis users is related to the frequency of use","volume":"209","author":"Becker","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.dcn.2015.10.004","article-title":"Longitudinal changes in white matter microstructure after heavy cannabis use","volume":"16","author":"Becker","year":"2015","journal-title":"Developmental Cognitive Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuropharm.2013.05.027","article-title":"Response inhibition and elevated parietal-cerebellar correlations in chronic adolescent cannabis users","volume":"84","author":"Behan","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0100","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.euroneuro.2014.11.018","article-title":"Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis","volume":"25","author":"Bhattacharyya","year":"2015","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/archgenpsychiatry.2011.161","article-title":"Induction of psychosis by \u03949-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing","volume":"69","author":"Bhattacharyya","year":"2012","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0115","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archgenpsychiatry.2009.17","article-title":"Modulation of mediotemporal and ventrostriatal function in humans by \u03949-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis","volume":"66","author":"Bhattacharyya","year":"2009","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0120","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1017\/S0033291714000920","article-title":"Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control","volume":"44","author":"Bhattacharyya","year":"2014","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0125","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of \u03949-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0130","first-page":"1","article-title":"Increased hippocampal engagement during learning as a marker of sensitivity to psychotomimetic effects of \u03949-THC","author":"Bhattacharyya","year":"2018","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0135","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0140","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/adb.12370","article-title":"Attenuated frontal and sensory inputs to the basal ganglia in cannabis users","volume":"22","author":"Blanco-Hinojo","year":"2017","journal-title":"Addiction Biology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0145","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neubiorev.2018.03.008","article-title":"Residual effects of cannabis use in adolescent and adult brains - A meta-analysis of fMRI studies","volume":"88","author":"Blest-Hopley","year":"2018","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0150","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00001756-200002280-00013","article-title":"Effects of frequent marijuana use on brain tissue volume and composition","volume":"11","author":"Block","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0155","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/00001756-200003200-00019","article-title":"Cerebellar hypoactivity in frequent marijuana users","volume":"11","author":"Block","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0091-3057(01)00771-7","article-title":"Effects of frequent marijuana use on memory-related regional cerebral blood flow","volume":"72","author":"Block","year":"2002","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0165","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature20153","article-title":"The effects of Delta(9)-tetrahydrocannabinol on the dopamine system","volume":"539","author":"Bloomfield","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0170","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.biopsych.2013.05.027","article-title":"Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms","volume":"75","author":"Bloomfield","year":"2014","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0175","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00213-014-3523-4","article-title":"The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study","volume":"231","author":"Bloomfield","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0180","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1162\/jocn.2009.21355","article-title":"Cannabinoid modulations of resting state EEG theta power and working memory are correlated in humans","volume":"22","author":"B\u00f6cker","year":"2010","journal-title":"Journal of Cognitive Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0185","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.neuroimage.2005.02.012","article-title":"Neural substrates of faulty decision-making in abstinent marijuana users","volume":"26","author":"Bolla","year":"2005","journal-title":"NeuroImage"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0190","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.biopsych.2008.05.011","article-title":"Neural basis of \u0394-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition","volume":"64","author":"Borgwardt","year":"2008","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0195","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.2174\/13816128113199990436","article-title":"Acute and non-acute effects of cannabis on human memory function: a critical review of neuroimaging studies","volume":"20","author":"Bossong","year":"2014","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0200","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1162\/jocn_a_00156","article-title":"Effects of \u03949-tetrahydrocannabinol administration on human encoding and recall memory function: a pharmacological FMRI study","volume":"24","author":"Bossong","year":"2012","journal-title":"Journal of Cognitive Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070074","article-title":"Default mode network in the effects of \u03949-Tetrahydrocannabinol (THC) on human executive function","volume":"8","author":"Bossong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0210","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.biopsych.2012.01.008","article-title":"Effects of \u03949-tetrahydrocannabinol on human working memory function","volume":"71","author":"Bossong","year":"2012","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0215","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s00213-015-3915-0","article-title":"Further human evidence for striatal dopamine release induced by administration of\u2206 9-tetrahydrocannabinol (THC): selectivity to limbic striatum","volume":"232","author":"Bossong","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0220","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.pneurobio.2010.06.010","article-title":"Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia","volume":"92","author":"Bossong","year":"2010","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0225","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/npp.2008.138","article-title":"\u03949-tetrahydrocannabinol induces dopamine release in the human striatum","volume":"34","author":"Bossong","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0230","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.euroneuro.2013.06.009","article-title":"The endocannabinoid system and emotional processing: a pharmacological fMRI study with 9-tetrahydrocannabinol","volume":"23","author":"Bossong","year":"2013","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0235","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.schres.2004.01.004","article-title":"Meta-analysis of the P300 and P50 waveforms in schizophrenia","volume":"70","author":"Bramon","year":"2004","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0240","first-page":"328","article-title":"Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition","volume":"295","author":"Breivogel","year":"2000","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0245","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1007\/s00213-016-4367-x","article-title":"Nicotinic acetylcholine receptor availability in cigarette smokers: effect of heavy caffeine or marijuana use","volume":"233","author":"Broyd","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0250","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.biopsych.2015.12.002","article-title":"Acute and chronic effects of cannabinoids on human cognition\u2014a systematic review","volume":"79","author":"Broyd","year":"2016","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0255","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12888-015-0656-x","article-title":"Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis","volume":"15","author":"Buchy","year":"2015","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0260","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrn3475","article-title":"Power failure: why small sample size undermines the reliability of neuroscience","volume":"14","author":"Button","year":"2013","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0265","first-page":"1922","article-title":"Adverse effects of cannabis on adolescent brain development: a longitudinal study","volume":"27","author":"Camchong","year":"2017","journal-title":"Cerebral Cortex"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0270","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.drugalcdep.2015.07.671","article-title":"Impaired learning from errors in cannabis users: dorsal anterior cingulate cortex and hippocampus hypoactivity","volume":"155","author":"Carey","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0275","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.phrs.2009.11.008","article-title":"Altered regulation of glutamate release and decreased functional activity and expression of GLT1 and GLAST glutamate transporters in the hippocampus of adolescent rats perinatally exposed to Delta(9)-THC","volume":"61","author":"Castaldo","year":"2010","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0280","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0285","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/adb.12116","article-title":"[18 F] MK-9470 PET measurement of cannabinoid CB 1 receptor availability in chronic cannabis users","volume":"20","author":"Ceccarini","year":"2015","journal-title":"Addiction Biology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0290","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jamapediatrics.2016.3624","article-title":"Association of state recreational marijuana laws with adolescent marijuana use","volume":"171","author":"Cerd\u00e1","year":"2017","journal-title":"JAMA Pediatrics"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0295","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1523\/JNEUROSCI.18-14-05322.1998","article-title":"Hippocampal neurotoxicity of \u03949-tetrahydrocannabinol","volume":"18","author":"Chan","year":"1998","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0300","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11481-005-9005-z","article-title":"Combined and independent effects of chronic marijuana use and HIV on brain metabolites","volume":"1","author":"Chang","year":"2006","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0305","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/brain\/awl064","article-title":"Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation","volume":"129","author":"Chang","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0310","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1177\/0269881114550354","article-title":"Resting state functional magnetic resonance imaging reveals distinct brain activity in heavy cannabis users - a multi-voxel pattern analysis","volume":"28","author":"Cheng","year":"2014","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0315","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/scan\/nsl024","article-title":"Social cognitive development during adolescence","volume":"1","author":"Choudhury","year":"2006","journal-title":"Social Cognitive and Affective Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0320","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12652","article-title":"Alteration to hippocampal volume and shape confined to cannabis dependence: a multi-site study","author":"Chye","year":"2018","journal-title":"Addiction Biology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0325","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00213-017-4606-9","article-title":"Orbitofrontal and caudate volumes in cannabis users: a multi-site mega-analysis comparing dependent versus non-dependent users","volume":"234","author":"Chye","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0330","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1007\/s00213-017-4620-y","article-title":"Cannabis-related hippocampal volumetric abnormalities specific to subregions in dependent users","volume":"234","author":"Chye","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0335","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/jama.1977.03270390045024","article-title":"Absence of cerebral atrophy in chronic cannabis users. Evaluation by computerized transaxial tomography","volume":"237","author":"Co","year":"1977","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0340","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/npp.2014.213","article-title":"Functional genetic variation of the cannabinoid receptor 1 and cannabis use interact on prefrontal connectivity and related working memory behavior","volume":"40","author":"Colizzi","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0345","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neubiorev.2016.03.010","article-title":"Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence","volume":"64","author":"Colizzi","year":"2016","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0350","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1468-1331.2006.01639.x","article-title":"Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis","volume":"14","author":"Collin","year":"2007","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0355","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/YCO.0b013e328361eae5","article-title":"Changes in cannabis use among young people: impact on mental health","volume":"26","author":"Copeland","year":"2013","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0360","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1016\/j.neuroimage.2011.09.046","article-title":"Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls","volume":"59","author":"Cousijn","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0365","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1002\/hbm.22342","article-title":"Effect of baseline cannabis use and working-memory network function on changes in cannabis use in heavy cannabis users: a prospective fMRI study","volume":"35","author":"Cousijn","year":"2014","journal-title":"Human Brain Mapping"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0370","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1369-1600.2012.00498.x","article-title":"Individual differences in decision making and reward processing predict changes in cannabis use: a prospective functional magnetic resonance imaging study","volume":"18","author":"Cousijn","year":"2013","journal-title":"Addiction Biology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0375","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pbb.2008.10.022","article-title":"N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: A 3 T magnetic resonance spectroscopy study","volume":"92","author":"Cowan","year":"2009","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0380","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11065-012-9222-1","article-title":"Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences","volume":"23","author":"Crane","year":"2013","journal-title":"Neuropsychology Review"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0385","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/ADM.0b013e31820cdd57","article-title":"Effects of chronic, heavy cannabis use on executive functions","volume":"5","author":"Crean","year":"2011","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184923","article-title":"The relation between statistical power and inference in fMRI","volume":"12","author":"Cremers","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0395","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300340","article-title":"Effects of cannabidiol (CBD) on regional cerebral blood flow","volume":"29","author":"Crippa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0400","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hup.1048","article-title":"Cannabis and anxiety: a critical review of the evidence","volume":"24","author":"Crippa","year":"2009","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0405","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.schres.2013.04.009","article-title":"Cannabis use, cognition and brain structure in first-episode psychosis","volume":"147","author":"Cunha","year":"2013","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0410","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrn.2016.28","article-title":"Keep off the grass? Cannabis, cognition and addiction","volume":"17","author":"Curran","year":"2016","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S003329171800226X","article-title":"Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?","author":"Curran","year":"2018","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0420","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00213-002-1169-0","article-title":"Cognitive and subjective dose-response effects of acute oral \u0394 9-tetrahydrocannabinol (THC) in infrequent cannabis users","volume":"164","author":"Curran","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0425","doi-asserted-by":"crossref","first-page":"915","DOI":"10.6004\/jnccn.2016.0094","article-title":"Cannabinoids for symptom management and cancer therapy: The evidence","volume":"14","author":"Davis","year":"2016","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0430","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.drugalcdep.2013.05.020","article-title":"Neural mechanisms of risky decision-making and reward response in adolescent onset cannabis use disorder","volume":"133","author":"De Bellis","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0435","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/mp.2016.21","article-title":"Deficits in striatal dopamine release in cannabis dependence","volume":"22","author":"van de Giessen","year":"2017","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0440","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-7517-3-17","article-title":"A preliminary DTI study showing no brain structural change associated with adolescent cannabis use","volume":"3","author":"Delisi","year":"2006","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0445","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuroimage.2018.05.011","article-title":"A comprehensive evaluation of increasing temporal resolution with multiband-accelerated protocols and effects on statistical outcome measures in fMRI","volume":"176","author":"Demetriou","year":"2018","journal-title":"NeuroImage"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0450","first-page":"242","article-title":"Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol","volume":"114","author":"Demirakca","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0455","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0460","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of Cannabidiol on Drop Seizures in the Lennox\u2013Gastaut Syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0465","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.biopsych.2012.06.020","article-title":"Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users","volume":"72","author":"Di Forti","year":"2012","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0470","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2215-0366(14)00117-5","article-title":"Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study","volume":"2","author":"Di Forti","year":"2015","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0475","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1192\/bjp.bp.109.064220","article-title":"High-potency cannabis and the risk of psychosis","volume":"195","author":"Di Forti","year":"2009","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0480","series-title":"Proceedings of the national academy of sciences of the United States of America","first-page":"10269","article-title":"Mesolimbic dopaminergic decline after cannabinoid withdrawal","volume":"Vol. 95","author":"Diana","year":"1998"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0485","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00787-007-0663-7","article-title":"Affect dysregulation in cannabis abusers","volume":"17","author":"Dorard","year":"2008","journal-title":"European Child & Adolescent Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0490","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1097\/00001756-200112210-00024","article-title":"Delta 9-tetrahydrocannabinol induces the apoptotic pathway in cultured cortical neurones via activation of the CB1 receptor","volume":"12","author":"Downer","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0495","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1007\/s00213-015-3968-0","article-title":"The role of machine learning in neuroimaging for drug discovery and development","volume":"232","author":"Doyle","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0500","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000366485","article-title":"Brain metabolism in substance-induced psychosis and schizophrenia: a preliminary PET study","volume":"70","author":"Dragogna","year":"2014","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0505","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bpsc.2015.09.008","article-title":"Rapid changes in CB1 receptor availability in cannabis dependent males after abstinence from cannabis","volume":"1","author":"D'Souza","year":"2016","journal-title":"Biological Psychiatry Cognitive Neuroscience and Neuroimaging"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0510","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis","volume":"29","author":"D'Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0515","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.npp.1301643","article-title":"Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis","volume":"33","author":"D'Souza","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0520","doi-asserted-by":"crossref","first-page":"11","DOI":"10.31887\/DCNS.2014.16.1\/rduman","article-title":"Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections","volume":"16","author":"Duman","year":"2014","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0525","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.neuroimage.2011.10.065","article-title":"The future of ultra-high field MRI and fMRI for study of the human brain","volume":"62","author":"Duyn","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0530","series-title":"Proceedings of the national academy of sciences of the United States of America","first-page":"7900","article-title":"Cluster failure: Why fMRI inferences for spatial extent have inflated false-positive rates","volume":"Vol. 113","author":"Eklund","year":"2016"},{"issue":"3","key":"10.1016\/j.pharmthera.2018.10.006_bb6000","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.neuroimage.2004.07.032","article-title":"Abnormal brain activity in prefrontal brain regions in abstinent marijuana users","volume":"23","author":"Eldreth","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0535","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","article-title":"Changes in cannabis potency over the last 2 decades (1995\u20132014): analysis of current data in the United States","volume":"79","author":"ElSohly","year":"2016","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0540","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0269881112460109","article-title":"Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment","volume":"27","author":"Englund","year":"2013","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119150","article-title":"Alterations of monetary reward and punishment processing in chronic cannabis users: An fMRI study","volume":"10","author":"Enzi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0550","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaac.2013.12.007","article-title":"White matter abnormalities and cognitive impairment in early-onset schizophrenia-spectrum disorders","volume":"53","author":"Epstein","year":"2014","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0555","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pscychresns.2014.10.010","article-title":"White matter fractional anisotropy over two time points in early onset schizophrenia and adolescent cannabis use disorder: A naturalistic diffusion tensor imaging study","volume":"232","author":"Epstein","year":"2015","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0560","article-title":"FMRIPrep: a robust preprocessing pipeline for functional MRI","author":"Esteban","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0565","series-title":"European drug report 2018: Trends and developments","author":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).","year":"2018"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0570","first-page":"838","article-title":"Cannabinoid agonists stimulate both receptor-and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones","volume":"42","author":"Felder","year":"1992","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0575","doi-asserted-by":"crossref","first-page":"16913","DOI":"10.1073\/pnas.1415297111","article-title":"Long-term effects of marijuana use on the brain","volume":"111","author":"Filbey","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0580","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/npp.2017.44","article-title":"Residual effects of THC via novel measures of brain perfusion and metabolism in a large group of chronic cannabis users","volume":"43","author":"Filbey","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0585","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.drugalcdep.2014.04.002","article-title":"Differential reward network functional connectivity in cannabis dependent and non-dependent users","volume":"140","author":"Filbey","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0590","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbr.2015.07.029","article-title":"Combined effects of marijuana and nicotine on memory performance and hippocampal volume","volume":"293","author":"Filbey","year":"2015","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0595","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3109\/00952990.2013.841710","article-title":"Functional connectivity in inhibitory control networks and severity of cannabis use disorder","volume":"39","author":"Filbey","year":"2013","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0600","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.schres.2014.04.033","article-title":"Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC","volume":"158","author":"Fischer","year":"2014","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0605","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tics.2006.02.008","article-title":"Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits","volume":"10","author":"Fletcher","year":"2006","journal-title":"Trends in Cognitive Sciences"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0610","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fpsyt.2014.00130","article-title":"Unique functional abnormalities in youth with combined marijuana use and depression: an FMRI study","volume":"5","author":"Ford","year":"2014","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0615","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/schbul\/sbu098","article-title":"How cannabis causes paranoia: using the intravenous administration of 9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia","volume":"41","author":"Freeman","year":"2015","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0620","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.schres.2013.06.008","article-title":"Persecutory ideation and a history of cannabis use","volume":"148","author":"Freeman","year":"2013","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0625","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/ijnp\/pyx082","article-title":"Cannabis Dampens the effects of music in brain regions sensitive to reward and emotion","volume":"21","author":"Freeman","year":"2018","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0630","first-page":"1","article-title":"Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands","author":"Freeman","year":"2018","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0635","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1017\/S0033291715001178","article-title":"Examining the profile of high-potency cannabis and its association with severity of cannabis dependence","volume":"45","author":"Freeman","year":"2015","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0640","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1056\/NEJMra1407304","article-title":"Cannabinoids in the Treatment of Epilepsy","volume":"373","author":"Friedman","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0645","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S1461145709990617","article-title":"Modulation of effective connectivity during emotional processing by \u03949-tetrahydrocannabinol and cannabidiol","volume":"13","author":"Fusar-Poli","year":"2010","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0650","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archgenpsychiatry.2008.519","article-title":"Distinct effects of \u03949-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing","volume":"66","author":"Fusar-Poli","year":"2009","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0655","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.biopsych.2015.08.001","article-title":"Association between cannabis and psychosis: epidemiologic evidence","volume":"79","author":"Gage","year":"2016","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0660","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1523\/JNEUROSCI.4745-13.2014","article-title":"Cannabis use is quantitatively associated with nucleus accumbens and amygdala abnormalities in young adult recreational users","volume":"34","author":"Gilman","year":"2014","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0665","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain","volume":"77","author":"Glass","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0670","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/scan\/nsu080","article-title":"Basal forebrain moderates the magnitude of task-dependent amygdala functional connectivity","volume":"10","author":"Gorka","year":"2015","journal-title":"Social Cognitive and Affective Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0675","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/npp.2015.359","article-title":"Cannabinoid modulation of frontolimbic activation and connectivity during volitional regulation of negative affect","volume":"41","author":"Gorka","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0680","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejps.2004.07.013","article-title":"Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors","volume":"23","author":"Govaerts","year":"2004","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0685","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/09595230310001613976","article-title":"Being stoned: a review of self-reported cannabis effects","volume":"22","author":"Green","year":"2003","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0690","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.euroneuro.2018.04.004","article-title":"Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity","volume":"28","author":"Grimm","year":"2018","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0695","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0700","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.drugalcdep.2009.06.019","article-title":"Altered affective response in marijuana smokers: an FMRI study","volume":"105","author":"Gruber","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0705","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3389\/fphar.2017.00983","article-title":"The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity and Improved Executive Function after 3 Months of Treatment","volume":"8","author":"Gruber","year":"2017","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2018.10.006_bb0710","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1037\/a0023034","article-title":"Why so impulsive? White matter alterations are associated with impulsivity in chronic marijuana smokers","volume":"19","author":"Gruber","year":"2011","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0715","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cogbrainres.2005.02.016","article-title":"Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation","volume":"23","author":"Gruber","year":"2005","journal-title":"Brain Research. Cognitive Brain Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0720","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-014-3662-7","article-title":"Dimensional psychiatry: reward dysfunction and depressive mood across psychiatric disorders","volume":"232","author":"Hagele","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0725","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ana.410130219","article-title":"Neurological and neuroradiological examination of chronic cannabis smokers","volume":"13","author":"Hannerz","year":"1983","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0730","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1039\/C6NP00074F","article-title":"Phytocannabinoids: A unified critical inventory","volume":"33","author":"Hanu\u0161","year":"2016","journal-title":"Natural Product Reports"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0735","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/jamapsychiatry.2015.1858","article-title":"Prevalence of Marijuana use disorders in the United States between 2001-2002 and 2012-2013","volume":"72","author":"Hasin","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0740","first-page":"657","article-title":"Cannabis sativa: effects on brain function and ultrastructure in rhesus monkeys","volume":"15","author":"Heath","year":"1980","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0745","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1017\/S1461145711000526","article-title":"Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study","volume":"14","author":"van Hell","year":"2011","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0750","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00213-011-2428-8","article-title":"Involvement of the endocannabinoid system in reward processing in the human brain","volume":"219","author":"van Hell","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0755","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.euroneuro.2009.11.010","article-title":"Chronic effects of cannabis use on the human reward system: an fMRI study","volume":"20","author":"van Hell","year":"2010","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0760","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0765","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.biopsych.2006.08.027","article-title":"Dorsolateral prefrontal cortex N-acetylaspartate\/total creatine (NAA\/tCr) loss in male recreational cannabis users","volume":"61","author":"Hermann","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0770","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1038\/npp.2009.67","article-title":"Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users","volume":"34","author":"Hester","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0775","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pscychresns.2016.05.009","article-title":"Lifetime use of cannabis from longitudinal assessments, cannabinoid receptor (CNR1) variation, and reduced volume of the right anterior cingulate","volume":"255","author":"Hill","year":"2016","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0780","doi-asserted-by":"crossref","DOI":"10.1111\/add.14243","article-title":"Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal","author":"Hindocha","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0785","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.euroneuro.2014.11.014","article-title":"Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users","volume":"25","author":"Hindocha","year":"2015","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(18)30088-9","article-title":"Solving the problem of cannabis quantification","volume":"5","author":"Hindocha","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0795","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/0269881114527359","article-title":"Emotional processing deficits in chronic cannabis use: a replication and extension","volume":"28","author":"Hindocha","year":"2014","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0800","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mp.2011.82","article-title":"Reversible and regionally selective downregulation of brain cannabinoid CB 1 receptors in chronic daily cannabis smokers","volume":"17","author":"Hirvonen","year":"2012","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjp.bp.113.138578","article-title":"A neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic)","volume":"205","author":"Howes","year":"2014","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0810","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00008877-200509000-00023","article-title":"Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids","volume":"16","author":"Ilan","year":"2005","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0815","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.biopsych.2006.02.014","article-title":"Functional correlates of verbal memory deficits emerging during nicotine withdrawal in abstinent adolescent cannabis users","volume":"61","author":"Jacobsen","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0820","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00213-012-2674-4","article-title":"Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users","volume":"222","author":"Jacobus","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0825","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.2174\/13816128113199990426","article-title":"Effects of cannabis on the adolescent brain","volume":"20","author":"Jacobus","year":"2014","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0830","first-page":"561","article-title":"Cannabis use and memory brain function in adolescent boys: a cross-sectional multicenter functional magnetic resonance imaging study","volume":"49","author":"Jager","year":"2010","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0835","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/02791072.2013.785837","article-title":"Tentative evidence for striatal hyperactivity in adolescent cannabis-using boys: a cross-sectional multicenter fMRI study","volume":"45","author":"Jager","year":"2013","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0840","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s00213-005-0298-7","article-title":"Long-term effects of frequent cannabis use on working memory and attention: an fMRI study","volume":"185","author":"Jager","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0845","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1874473710801020114","article-title":"Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: an overview of animal and human research","volume":"1","author":"Jager","year":"2008","journal-title":"Current Drug Abuse Reviews"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0850","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.euroneuro.2006.10.003","article-title":"Effects of frequent cannabis use on hippocampal activity during an associative memory task","volume":"17","author":"Jager","year":"2007","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0855","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.schres.2011.02.014","article-title":"Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS)","volume":"128","author":"James","year":"2011","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0860","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pscychresns.2013.07.012","article-title":"The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: A systematic review","volume":"214","author":"James","year":"2013","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0865","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.6","article-title":"THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction","volume":"3","author":"Jansma","year":"2013","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0870","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00213-004-1885-8","article-title":"Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study","volume":"176","author":"Kanayama","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0875","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0880","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-2999(74)90129-0","article-title":"Cannabidiol interferes with the effects of \u03949-tetrahydrocannabinol in man","volume":"28","author":"Karniol","year":"1974","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0885","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.dcn.2015.05.005","article-title":"Does incentive-elicited nucleus accumbens activation differ by substance of abuse? An examination with adolescents","volume":"16","author":"Karoly","year":"2015","journal-title":"Developmental Cognitive Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0890","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1523\/JNEUROSCI.21-23-09506.2001","article-title":"Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission","volume":"21","author":"Katona","year":"2001","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0895","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.neuropharm.2003.11.005","article-title":"\u03949-Tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture","volume":"46","author":"Kelley","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0900","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.nicl.2016.09.012","article-title":"Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults","volume":"13","author":"Kelly","year":"2017","journal-title":"Neuroimage Clinnical"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0905","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/brain.2011.0053","article-title":"Structural network topology revealed by white matter tractography in cannabis users: a graph theoretical analysis","volume":"1","author":"Kim","year":"2011","journal-title":"Brain Connectivity"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0910","doi-asserted-by":"crossref","first-page":"17923","DOI":"10.1523\/JNEUROSCI.4148-11.2011","article-title":"Altered brain activation during visuomotor integration in chronic active cannabis users: relationship to cortisol levels","volume":"31","author":"King","year":"2011","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0915","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.neuroimage.2012.07.051","article-title":"Manipulating brain connectivity with \u03b49-tetrahydrocannabinol: a pharmacological resting state FMRI study","volume":"63","author":"Klumpers","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0920","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152482","article-title":"Grey matter changes associated with heavy cannabis use: A longitudinal sMRI study","volume":"11","author":"Koenders","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0925","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/0269881117718380","article-title":"Longitudinal study of hippocampal volumes in heavy cannabis users","volume":"31","author":"Koenders","year":"2017","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0930","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jama.1972.03210010017004","article-title":"Toxic effects of chronic marihuana use","volume":"222","author":"Kolansky","year":"1972","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0935","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/jama.1977.03270390047025","article-title":"Computed tomographic examination of heavy marijuana smokers","volume":"237","author":"Kuehnle","year":"1977","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0940","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0006-8993(88)91597-1","article-title":"Quantitative changes in hippocampal structure following long-term exposure to \u03949-tetrahydrocannabinol: possible mediation by glucocorticoid systems","volume":"443","author":"Landfield","year":"1988","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0945","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0950","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1369-1600.2011.00356.x","article-title":"Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study","volume":"17","author":"Leroy","year":"2012","journal-title":"Addiction Biology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0955","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jaac.2016.12.014","article-title":"Evidence for the risks and consequences of adolescent cannabis exposure","volume":"56","author":"Levine","year":"2017","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0960","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0965","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1111\/add.13882","article-title":"Nucleus accumbens functional connectivity at age 20 is associated with trajectory of adolescent cannabis use and predicts psychosocial functioning in young adulthood","volume":"112","author":"Lichenstein","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0970","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.dcn.2015.08.002","article-title":"Aberrant orbitofrontal connectivity in marijuana smoking adolescents","volume":"16","author":"Lopez-Larson","year":"2015","journal-title":"Developmental Cognitive Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0975","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.2174\/1381612822666160805155922","article-title":"Adolescent cannabis use: What is the evidence for functional brain alteration?","volume":"22","author":"Lorenzetti","year":"2016","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0980","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3109\/10826084.2010.482443","article-title":"Structural MRI findings in long-term cannabis users: what do we know?","volume":"45","author":"Lorenzetti","year":"2010","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0985","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1192\/bjp.bp.114.151407","article-title":"Gross morphological brain changes with chronic, heavy cannabis use","volume":"206","author":"Lorenzetti","year":"2015","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0990","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.biopsych.2015.11.013","article-title":"The role of cannabinoids in neuroanatomic alterations in cannabis users","volume":"79","author":"Lorenzetti","year":"2016","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb0995","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/jamapsychiatry.2016.3084","article-title":"Disruption of reward processing in addiction: An image-based meta-analysis of functional magnetic resonance imaging studies","volume":"74","author":"Luijten","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1000","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0892-0362(01)00165-9","article-title":"Frontal lobe dysfunction in long-term cannabis users","volume":"23","author":"Lundqvist","year":"2001","journal-title":"Neurotoxicology and Teratology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bpsc.2017.11.004","article-title":"Subcortical local functional hyperconnectivity in cannabis dependence","volume":"3","author":"Manza","year":"2018","journal-title":"Biological Psychiatry Cognitive Neuroscience and Neuroimaging"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1010","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/schbul\/sbw003","article-title":"Meta-analysis of the association between the level of cannabis use and risk of psychosis","volume":"42","author":"Marconi","year":"2016","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016843","article-title":"A randomised controlled cross-over double-blind pilot study protocol on THC: CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity","volume":"7","author":"Marinelli","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1020","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/jamapsychiatry.2016.1161","article-title":"Association of Marijuana use with blunted nucleus accumbens response to reward anticipation","volume":"73","author":"Martz","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1025","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1017\/S0033291708004741","article-title":"Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis","volume":"39","author":"Mason","year":"2009","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1600-0447.1999.tb10916.x","article-title":"Regional cerebral blood flow and depersonalization after tetrahydrocannabinol adrninistration","volume":"100","author":"Mathew","year":"1999","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1035","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1360-0443.1986.tb00369.x","article-title":"Regional cerebral blood flow in marijuana smokers","volume":"81","author":"Mathew","year":"1986","journal-title":"British Journal of Addiction"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1040","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0024-3205(93)90239-Y","article-title":"Acute changes in cerebral blood-flow after smoking Marijuana","volume":"52","author":"Mathew","year":"1993","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1045","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/S0024-3205(97)00195-1","article-title":"Marijuana intoxication and brain activation in marijuana smokers","volume":"60","author":"Mathew","year":"1997","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1050","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0006-3223(93)90171-9","article-title":"Depersonalization after marijuana smoking","volume":"33","author":"Mathew","year":"1993","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0006-3223(92)90019-V","article-title":"Changes in middle cerebral artery velocity after marijuana","volume":"32","author":"Mathew","year":"1992","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1060","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/jcbfm.1992.106","article-title":"Regional cerebral blood-flow after marijuana smoking","volume":"12","author":"Mathew","year":"1992","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0447.1989.tb08579.x","article-title":"Acute changes in cerebral blood flow associated with marijuana smoking","volume":"79","author":"Mathew","year":"1989","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-8993(98)00375-8","article-title":"Cerebellar activity and disturbed time sense after THC","volume":"797","author":"Mathew","year":"1998","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0925-4927(02)00069-0","article-title":"Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography","volume":"116","author":"Mathew","year":"2002","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugalcdep.2004.06.011","article-title":"Altered brain tissue composition in heavy marijuana users","volume":"77","author":"Matochik","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.pharmthera.2018.10.006_bb1085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: A multicenter randomized controlled trial","volume":"175","author":"McGuire","year":"2017","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1090","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1369-1600.2009.00166.x","article-title":"Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects","volume":"14","author":"Medina","year":"2009","journal-title":"Addiction Biology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ntt.2006.10.010","article-title":"Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry","volume":"29","author":"Medina","year":"2007","journal-title":"Neurotoxicology and Teratology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1100","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/npp.2012.232","article-title":"Dopamine response to psychosocial stress in chronic cannabis users: A PET study with [11C]-+-PHNO","volume":"38","author":"Mizrahi","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2006.12.003","article-title":"N-acetylaspartate in the CNS: From neurodiagnostics to neurobiology","volume":"81","author":"Moffett","year":"2007","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1110","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.225","article-title":"Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males","volume":"6","author":"Mokrysz","year":"2016","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1115","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","article-title":"Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review","volume":"370","author":"Moore","year":"2007","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1120","series-title":"Du hachisch et de l'alienation mentale etudes psychologiques","author":"Moreau","year":"1845"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fpsyt.2018.00175","article-title":"Larger gray matter volume in the basal ganglia of heavy cannabis users detected by voxel-based morphometry and subcortical volumetric analysis","volume":"9","author":"Moreno-Alcazar","year":"2018","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1130","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.219","article-title":"AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers","volume":"6","author":"Morgan","year":"2016","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1192\/bjp.bp.110.077503","article-title":"Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study","volume":"197","author":"Morgan","year":"2010","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1140","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.addbeh.2013.03.011","article-title":"Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings","volume":"38","author":"Morgan","year":"2013","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1145","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1017\/S0033291709005522","article-title":"The acute effects of synthetic intravenous \u0394 9-tetrahydrocannabinol on psychosis, mood and cognitive functioning","volume":"39","author":"Morrison","year":"2009","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1150","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/npp.2010.222","article-title":"Disruption of frontal theta coherence by \u0394 9-tetrahydrocannabinol is associated with positive psychotic symptoms","volume":"36","author":"Morrison","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hup.1166","article-title":"Synthetic delta-9-tetrahydrocannabinol elicits schizophrenia-like negative symptoms which are distinct from sedation","volume":"26","author":"Morrison","year":"2011","journal-title":"Human Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2018.10.006_bb1160","article-title":"Cannabis-based medicines for chronic neuropathic pain in adults","author":"Mucke","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1165","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.nicl.2013.04.011","article-title":"In vivo (1)H magnetic resonance spectroscopy in young-adult daily marijuana users","volume":"2","author":"Muetzel","year":"2013","journal-title":"Neuroimage Clinical"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1170","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1176\/ajp.2006.163.7.1245","article-title":"A validation of event-related FMRI comparisons between users of cocaine, nicotine, or cannabis and control subjects","volume":"163","author":"Murphy","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1175","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nrn2253","article-title":"Cannabis, the mind and society: the hash realities","volume":"8","author":"Murray","year":"2007","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1180","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jpain.2007.10.018","article-title":"Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy","volume":"9","author":"Narang","year":"2008","journal-title":"The Journal of Pain"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1185","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.neuroimage.2009.07.022","article-title":"Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users","volume":"49","author":"Nestor","year":"2010","journal-title":"NeuroImage"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1190","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.neuroimage.2007.12.059","article-title":"Deficits in learning and memory: parahippocampal hyperactivity and frontocortical hypoactivity in cannabis users","volume":"40","author":"Nestor","year":"2008","journal-title":"NeuroImage"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1195","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1523\/JNEUROSCI.3592-16.2017","article-title":"Power-up: A reanalysis of 'power failure' in neuroscience using mixture modeling","volume":"37","author":"Nord","year":"2017","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1200","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1097\/00001756-200011270-00047","article-title":"Acute marijuana effects on rCBF and cognition: a PET study","volume":"11","author":"O'leary","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1205","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0893-133X(01)00425-0","article-title":"Effects of smoking marijuana on brain perfusion and cognition","volume":"26","author":"O'Leary","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/hup.832","article-title":"Effects of smoking marijuana on focal attention and brain blood flow","volume":"22","author":"O'leary","year":"2007","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1215","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/00952990.2013.848213","article-title":"Altered resting-state connectivity in adolescent cannabis users","volume":"39","author":"Orr","year":"2013","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nicl.2016.06.006","article-title":"Recreational marijuana use impacts white matter integrity and subcortical (but not cortical) morphometry","volume":"12","author":"Orr","year":"2016","journal-title":"Neuroimage Clinical"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1225","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/jamapsychiatry.2015.1054","article-title":"Shared predisposition in the association between cannabis use and subcortical brain structure","volume":"72","author":"Pagliaccio","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1230","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/FBP.0b013e32835a7c4d","article-title":"\u03949-Tetrahydrocannabinol acts as a partial agonist\/antagonist in mice","volume":"23","author":"Paronis","year":"2012","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1235","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41593-018-0206-1","article-title":"GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia","volume":"21","author":"Pasman","year":"2018","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1240","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1245","first-page":"75","article-title":"Recent-onset schizophrenia and adolescent cannabis use: MRI evidence for structural hyperconnectivity?","volume":"42","author":"Peters","year":"2009","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0024-3205(98)00238-0","article-title":"Complex pharmacology of natural cannabinoids: Evidence for partial agonist activity of \u03949-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors","volume":"63","author":"Petitet","year":"1998","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1255","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.5603-07.2008","article-title":"Cannabinoid modulation of amygdala reactivity to social signals of threat in humans","volume":"28","author":"Phan","year":"2008","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1260","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1038\/npp.2014.110","article-title":"Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivors","volume":"39","author":"Pietrzak","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1265","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/13556210500123217","article-title":"Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops","volume":"10","author":"Pijlman","year":"2005","journal-title":"Addiction Biology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1270","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1037\/1064-1297.16.1.22","article-title":"Cannabis and motor function: fMRI changes following 28 days of discontinuation","volume":"16","author":"Pillay","year":"2008","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1275","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drugalcdep.2004.05.009","article-title":"Neurophysiology of motor function following cannabis discontinuation in chronic cannabis smokers: an fMRI study","volume":"76","author":"Pillay","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.drugalcdep.2010.05.004","article-title":"Processing dynamic facial affect in frequent cannabis-users: evidence of deficits in the speed of identifying emotional expressions","volume":"112","author":"Platt","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1285","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.dcn.2014.06.001","article-title":"Is \u201cefficiency\u201d a useful concept in cognitive neuroscience?","volume":"11","author":"Poldrack","year":"2015","journal-title":"Developmental Cognitive Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1290","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.neuro.2009.12.002","article-title":"Endocannabinoid signaling in neurotoxicity and neuroprotection","volume":"31","author":"Pope","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1295","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1556-4029.2007.00603.x","article-title":"Potency of \u03949\u2013THC and other cannabinoids in cannabis in England in 2005: Implications for psychoactivity and pharmacology","volume":"53","author":"Potter","year":"2008","journal-title":"Journal of Forensic Sciences"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1300","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/dta.2368","article-title":"Potency of \u03949\u2013tetrahydrocannabinol and other cannabinoids in cannabis in England in 2016: Implications for public health and pharmacology","volume":"10","author":"Potter","year":"2018","journal-title":"Drug Testing and Analysis"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1305","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuroimage.2011.02.044","article-title":"Neurochemical alterations in adolescent chronic marijuana smokers: a proton MRS study","volume":"57","author":"Prescot","year":"2011","journal-title":"NeuroImage"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1310","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.drugalcdep.2013.02.028","article-title":"gamma-Amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers","volume":"129","author":"Prescot","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1315","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpsychires.2013.12.008","article-title":"Functional connectivity alterations in brain networks relevant to self-awareness in chronic cannabis users","volume":"51","author":"Pujol","year":"2014","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1320","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nlm.2013.09.009","article-title":"Cannabinoid modulation of prefrontal\u2013limbic activation during fear extinction learning and recall in humans","volume":"113","author":"Rabinak","year":"2014","journal-title":"Neurobiology of Learning and Memory"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1325","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/npp.2015.58","article-title":"GABA deficits enhance the psychotomimetic effects of \u0394 9-THC","volume":"40","author":"Radhakrishnan","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1330","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s11682-015-9488-z","article-title":"Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes","volume":"10","author":"Ramaekers","year":"2016","journal-title":"Brain Imaging and Behavior"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1335","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3389\/fnhum.2017.00398","article-title":"Comparison of medical and consumer wireless EEG systems for use in clinical trials","volume":"11","author":"Ratti","year":"2017","journal-title":"Frontiers in Human Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1340","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1073\/pnas.1316911111","article-title":"Longitudinal four-dimensional mapping of subcortical anatomy in human development","volume":"111","author":"Raznahan","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1345","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1523\/JNEUROSCI.4291-09.2009","article-title":"Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances","volume":"29","author":"Ren","year":"2009","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1350","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/mp.2015.36","article-title":"Telling true from false: cannabis users show increased susceptibility to false memories","volume":"20","author":"Riba","year":"2015","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1355","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/pcn.12085","article-title":"Is cannabis neurotoxic for the healthy brain? A meta-analytical review of structural brain alterations in non-psychotic users","volume":"67","author":"Rocchetti","year":"2013","journal-title":"Psychiatry and Clinical Neurosciences"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1360","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1365","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.molmed.2010.08.003","article-title":"Combined PET\/MRI: One step further in multimodality imaging","volume":"16","author":"Sauter","year":"2010","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1370","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0006-8993(87)91576-9","article-title":"Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC)","volume":"436","author":"Scallet","year":"1987","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1375","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S2215-0366(16)30188-2","article-title":"Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study","volume":"3","author":"Schoeler","year":"2016","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1380","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/a0029117","article-title":"Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis","volume":"20","author":"Schreiner","year":"2012","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1385","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pscychresns.2007.04.018","article-title":"Abstinent adolescent marijuana users show altered fMRI response during spatial working memory","volume":"163","author":"Schweinsburg","year":"2008","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1390","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.drugalcdep.2005.01.009","article-title":"fMRI response to spatial working memory in adolescents with comorbid marijuana and alcohol use disorders","volume":"79","author":"Schweinsburg","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1395","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/02791072.2010.10400703","article-title":"The influence of recency of use on fMRI response during spatial working memory in adolescent marijuana users","volume":"42","author":"Schweinsburg","year":"2010","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1400","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamapsychiatry.2018.0335","article-title":"Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis","volume":"75","author":"Scott","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1405","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00213-008-1075-1","article-title":"Cerebral glucose metabolism and D2\/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography","volume":"197","author":"Sevy","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1410","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/mol.55.1.8","article-title":"\u03949-Tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture","volume":"55","author":"Shen","year":"1999","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1415","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1523\/JNEUROSCI.16-24-08057.1996","article-title":"Effects of chronic treatment with \u03949-tetrahydrocannabinol on cannabinoid-stimulated [35S] GTP\u03b3S autoradiography in rat brain","volume":"16","author":"Sim","year":"1996","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1420","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ntt.2005.12.008","article-title":"Effects of prenatal marijuana on visuospatial working memory: an fMRI study in young adults","volume":"28","author":"Smith","year":"2006","journal-title":"Neurotoxicology and Teratology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1425","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ntt.2016.05.010","article-title":"Prenatal marijuana exposure impacts executive functioning into young adulthood: An fMRI study","volume":"58","author":"Smith","year":"2016","journal-title":"Neurotoxicology and Teratology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1430","article-title":"Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy","volume":"12","author":"Smith","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1435","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/hipo.22427","article-title":"Cannabis-related episodic memory deficits and hippocampal morphological differences in healthy individuals and schizophrenia subjects","volume":"25","author":"Smith","year":"2015","journal-title":"Hippocampus"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1440","doi-asserted-by":"crossref","first-page":"461029","DOI":"10.1155\/2013\/461029","article-title":"A preliminary study of functional brain activation among marijuana users during performance of a virtual water maze task","volume":"2013","author":"Sneider","year":"2013","journal-title":"Journal of Addiction"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1445","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.euroneuro.2008.04.016","article-title":"Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers","volume":"18","author":"Sneider","year":"2008","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1450","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.dcn.2015.08.007","article-title":"Cannabis use in early adolescence: Evidence of amygdala hypersensitivity to signals of threat","volume":"16","author":"Spechler","year":"2015","journal-title":"Developmental Cognitive Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1455","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuroimage.2009.06.029","article-title":"Can recreational doses of THC produce significant dopamine release in the human striatum?","volume":"48","author":"Stokes","year":"2009","journal-title":"NeuroImage"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1465","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbr.2013.02.028","article-title":"Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana","volume":"246","author":"Sung","year":"2013","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1470","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bpsc.2016.03.002","article-title":"Neuroimaging intermediate phenotypes of executive control dysfunction in schizophrenia","volume":"1","author":"Sutcliffe","year":"2016","journal-title":"Biological Psychiatry Cogn itiveNeuroscience and Neuroimaging"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1475","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.38149.566979.AE","article-title":"Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial","volume":"329","author":"Svendsen","year":"2004","journal-title":"British Medical Journal"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1480","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00213-007-0823-y","article-title":"Functional MRI of inhibitory processing in abstinent adolescent marijuana users","volume":"194","author":"Tapert","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1485","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archpsyc.1972.01750250117016","article-title":"Psychiatric effects of hashish","volume":"27","author":"Tennant","year":"1972","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1490","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.neuroimage.2017.12.041","article-title":"Adolescent cannabis use and brain systems supporting adult working memory encoding, maintenance, and retrieval","volume":"169","author":"Tervo-Clemmens","year":"2018","journal-title":"NeuroImage"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1495","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.drugalcdep.2017.05.045","article-title":"Regular cannabis and alcohol use is associated with resting-state time course power spectra in incarcerated adolescents","volume":"178","author":"Thijssen","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1500","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0165-1781(86)90037-5","article-title":"Regional cerebral blood flow in long-term heavy cannabis use","volume":"17","author":"Tunving","year":"1986","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1505","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/10550490590899862","article-title":"Lack of hippocampal volume change in long-term heavy cannabis users","volume":"14","author":"Tzilos","year":"2005","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1510","series-title":"World drugs report","doi-asserted-by":"crossref","DOI":"10.18356\/d29e3f27-en","author":"United Nations Office on Drugs and Crime (UNODC)","year":"2018"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1515","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.biopsych.2011.12.018","article-title":"Dopamine release in chronic cannabis users: A C-11 raclopride positron emission tomography study","volume":"71","author":"Urban","year":"2012","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1520","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/npp.2011.227","article-title":"Effects of chronic marijuana use on brain activity during monetary decision-making","volume":"37","author":"Vaidya","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1525","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0925-4927(96)02817-X","article-title":"Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication","volume":"67","author":"Volkow","year":"1996","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1530","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jamapsychiatry.2015.3278","article-title":"Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review","volume":"73","author":"Volkow","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1535","doi-asserted-by":"crossref","first-page":"e3149","DOI":"10.1073\/pnas.1411228111","article-title":"Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity","volume":"111","author":"Volkow","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1540","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-002-1033-2","article-title":"Comparison of the subjective effects of \u0394 9-tetrahydrocannabinol and marijuana in humans","volume":"161","author":"Wachtel","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1545","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-007-0940-7","article-title":"Brain imaging study of the acute effects of Delta9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana","volume":"196","author":"Weinstein","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1550","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.2174\/1381612822666160822151323","article-title":"Brain imaging studies on the cognitive, pharmacological and neurobiological effects of cannabis in humans: Evidence from studies of adult users","volume":"22","author":"Weinstein","year":"2016","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1555","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1038\/npp.2016.67","article-title":"Cannabis abusers show hypofrontality and blunted brain responses to a stimulant challenge in females but not in males","volume":"41","author":"Wiers","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1560","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/BF02191147","article-title":"A cerebral computed tomography study of patients with drug-induced psychoses","volume":"241","author":"Wiesbeck","year":"1991","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1565","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jpain.2007.12.010","article-title":"A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain","volume":"9","author":"Wilsey","year":"2008","journal-title":"The Journal of Pain"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J069v19n01_01","article-title":"Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study","volume":"19","author":"Wilson","year":"2000","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1575","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/0269881117744995","article-title":"Neuroimaging meta-analysis of cannabis use studies reveals convergent functional alterations in brain regions supporting cognitive control and reward processing","volume":"32","author":"Yanes","year":"2018","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1580","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2014.03.031","article-title":"Pretreatment measures of brain structure and reward-processing brain function in cannabis dependence: An exploratory study of relationships with abstinence during behavioral treatment1","volume":"140","author":"Yip","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1585","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.201","article-title":"Hippocampal harms, protection and recovery following regular cannabis use","volume":"6","author":"Y\u00fccel","year":"2016","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1590","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1080\/00048670701689444","article-title":"Understanding drug addiction: a neuropsychological perspective","volume":"41","author":"Y\u00fccel","year":"2007","journal-title":"The Australian and New Zealand Journal Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1595","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/archpsyc.65.6.694","article-title":"Regional brain abnormalities associated with long-term heavy cannabis use","volume":"65","author":"Y\u00fccel","year":"2008","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1600","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/aws136","article-title":"Effect of long-term cannabis use on axonal fibre connectivity","volume":"135","author":"Zalesky","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1605","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/dta.1690","article-title":"Cannabis potency in the Venice area (Italy): Update 2013","volume":"7","author":"Zamengo","year":"2015","journal-title":"Drug Testing and Analysis"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1610","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1002\/hbm.23671","article-title":"Emotion regulation deficits in regular marijuana users","volume":"38","author":"Zimmermann","year":"2017","journal-title":"Human Brain Mapping"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1615","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00213-017-4803-6","article-title":"Altered orbitofrontal activity and dorsal striatal connectivity during emotion processing in dependent marijuana users after 28 days of abstinence","volume":"235","author":"Zimmermann","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2018.10.006_bb1620","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by \u0394 9-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725818301906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725818301906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T16:48:23Z","timestamp":1605286103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725818301906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":325,"alternative-id":["S0163725818301906"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2018.10.006","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neuropsychopharmacology of cannabis: A review of human imaging studies","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2018.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}